Abraxane and Factitious hyperthyroidism - from FDA reports


There is no Factitious hyperthyroidism reported by people who take Abraxane yet. This review analyzes which people have Factitious hyperthyroidism with Abraxane. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Abraxane and have Factitious hyperthyroidism, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Abraxane and have Factitious hyperthyroidism

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 18, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Factitious hyperthyroidism when taking Abraxane?

Expand the study to include all drugs with the same ingredients

Factitious hyperthyroidism and drugs with ingredients of paclitaxel.

Expand the study to include reports from both FDA and eHealthMe

Factitious hyperthyroidism and Abraxane from FDA and eHealthMe reports


Abraxane has active ingredients of paclitaxel. It is often used in breast cancer metastatic. (latest outcomes from Abraxane 7,514 users)

Factitious Hyperthyroidism

Factitious hyperthyroidism (ingestion of thyroid hormone) (latest reports from 2 Factitious hyperthyroidism patients).

Browse all side effects of Abraxane

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Factitious hyperthyroidism

Factitious hyperthyroidism

Could your condition cause Factitious hyperthyroidism

Factitious hyperthyroidism

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Abraxane and have Factitious hyperthyroidism.